Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OPY | EYE |
|---|---|---|
| Price | $121.68 | $16.52 |
| Change today | ▲ 1.29% | ▲ 0.73% |
| Market cap | $1.30B | $1.31B |
| Return, 3 months | +7.0% | -16.5% |
| Return, year to date | +69.3% | -36.0% |
| Return, 1 year | +73.1% | -41.3% |
| P/E (TTM) | 13.5 | 26.6 |
| P/B | 1.3 | 1.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 0.61% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 57 | 42 |
| 30-day volatility | 37.1% | 40.5% |
| Max drawdown, 1 year | -21.2% | -47.6% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
